Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumours of the Uterus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06977594
What this trial is testing

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer
Seoul National University Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT02340845
What this trial is testing

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

Who this might be right for
Cancer
Oeyama-Moto Cancer Research Foundation 100
Not applicableActive Not RecruitingNCT07486622
What this trial is testing

Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical Studies Balancing Scar - Free and Anti - Dissemination

Who this might be right for
Uterine FibroidsAdenomyosisEnlarged Uterus
Chang Zhou 25
Not applicableUnknownNCT05863377
What this trial is testing

Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer

Who this might be right for
Cervical Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 450
Testing effectiveness (Phase 2)UnknownNCT05105672
What this trial is testing

Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsSintilimab
The Affiliated Hospital of Xuzhou Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT00312286
What this trial is testing

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Who this might be right for
Papillomavirus Infections
Takeda 538
Not applicableStudy completedNCT01170299
What this trial is testing

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Who this might be right for
Anal CancerBladder CancerCervical Cancer+6 more
Royal Marsden NHS Foundation Trust 177
Not applicableStudy completedNCT05907187
What this trial is testing

Research in Ethno-Medicine and Education (REMED)

Who this might be right for
Cervical CancerHuman Papilloma VirusHPV+1 more
University of Miami 100
Not applicableActive Not RecruitingNCT03776630
What this trial is testing

Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors

Who this might be right for
Ovarian CancerEndometrial Cancer
Assistance Publique - Hôpitaux de Paris 363
Early research (Phase 1)Study completedNCT06048367
What this trial is testing

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorLung CancerPancreas Cancer+6 more
Sichuan Enray Pharmaceutical Sciences Company 19
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)WithdrawnNCT02348398
What this trial is testing

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01817530
What this trial is testing

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Who this might be right for
Heavy Uterine BleedingUterine Fibroids
AbbVie 571
Testing effectiveness (Phase 2)Looking for participantsNCT04098744
What this trial is testing

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Who this might be right for
CIN 2/3HPV InfectionPre-Cancerous Dysplasia+2 more
Frantz Viral Therapeutics, LLC 78
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Not applicableLooking for participantsNCT06774209
What this trial is testing

Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors

Who this might be right for
Endometrial Cancer
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT03542942
What this trial is testing

Exclusion of Non-involved Uterus From the Target Volume in Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
University Hospital, Ghent 21
Not applicableUnknownNCT04969445
What this trial is testing

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 647
Early research (Phase 1)Ended earlyNCT03924245
What this trial is testing

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more
Vanderbilt-Ingram Cancer Center 3
Next Page